Alumis draws Outperform at Oppenheimer
Oppenheimer downgrades Apple to Perform
U.S. filmmaker Joshua Oppenheimer, now based in Denmark, worries his "home country is perhaps becoming a dictatorship." "It ...
The card collecting industry has exploded in recent years to such an extent that industry leader Topps is now producing a Robert Oppenheimer card that's ...
Christopher Nolan has recently announced his reunion with Oppenheimer star Benny Safdie for his next movie.Safdie, who appeared as physicist Edward Teller in Nolan’s Oscar-winning movie, ...
British consumers’ appetite for home entertainment reached new heights in 2024, with the sector surpassing £5.1 billion ($6.4 ...
Seeking Alpha on MSN3d
Top momentum subsectors according to Oppenheimer: capital markets, software, and moreWithin financials ( XLF ), Wald mentioned capital markets and the SPDR S&P Capital Markets ETF ( KCE) as a top idea, ...
Did you know Christopher Nolan’s Oppenheimer script on his iconic red paper left Robert Downey Jr. nearly hypnotized? Read on ...
In a report released yesterday, Kristen Owen from Oppenheimer maintained a Buy rating on Cf Industries Holdings (CF – Research Report), with a ...
After working on director Christopher Nolan ’s award-winning drama Oppenheimer , Benny Safdie ( Are You There God? It’s Me, Margaret , The Stars at Noon , Licorice Pizza ) has been cast in Nolan’s ...
Shares of Apple have surged roughly 40% over the past nine months, but one analyst issued a cautious warning that it’s time to tap the brakes ahead of the company’s earnings report set for Thursday.
Oppenheimer upgraded Ovid Therapeutics (OVID) to Outperform from Perform with a $4 price target The firm says OV329’s promise is “quite real” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback